LEDIPASVIR\SOFOSBUVIR vs LENVATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LEDIPASVIR\SOFOSBUVIR vs LENVATINIB: Safety Overview
| Metric | LEDIPASVIR\SOFOSBUVIR | LENVATINIB |
|---|---|---|
| Total FAERS Reports | 23,616 | 33,766 |
| Deaths Reported | 1,371 | 4,449 |
| Death Rate | 5.8% | 13.2% |
| Hospitalizations | 4,031 | 19,975 |
| Average Patient Age | 57.9 yrs | 65.4 yrs |
| % Female Patients | 42.9% | 55.8% |
| FDA Approval Date | N/A | Feb 13, 2015 |
| Manufacturer | N/A | Eisai Inc. |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |